• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYSB2400153 贝伐珠单抗注射液 bevacizumab Injection Biological Products Supplementary Application 2024-07-16 view
CXSL2101163 贝伐珠单抗注射液 bevacizumab Injection Biological Products(2.2) New Drug Application 2021-06-30 Suzhou Suncadia Biopharmaceuticals Co Ltd view
CYSB2101317 贝伐珠单抗注射液 bevacizumab Injection Biological Products Supplementary Application 2022-01-05 Innovent Biologics (Suzhou) Co Ltd view
CYSB2300202 贝伐珠单抗注射液 bevacizumab Injection Biological Products Supplementary Application 2023-10-31 Bio-Thera Solutions Ltd view
CYSB2200053 贝伐珠单抗注射液 bevacizumab Injection Biological Products(原2) Supplementary Application 2022-02-21 Bio-Thera Solutions Ltd view
CXSS2200040 贝伐珠单抗注射液 bevacizumab Injection Biological Products(3.3) New Drug Application 2022-04-22 SinoCelltech Ltd view
CXSL2400202 贝伐珠单抗注射液 bevacizumab Injection Biological Products(2.2) New Drug Application 2024-03-23 Bio-Thera Solutions Ltd view
CYSB2101320 贝伐珠单抗注射液 bevacizumab Injection Biological Products(3.3) Supplementary Application 2021-12-31 TOT Biopharm Co Ltd view
CXSL2101219 贝伐珠单抗注射液 bevacizumab Injection Biological Products(2.2) New Drug Application 2021-07-27 Suzhou Suncadia Biopharmaceuticals Co Ltd view
CYSB2300063 贝伐珠单抗注射液 bevacizumab Injection Biological Products Supplementary Application 2023-03-23 Shandong BoAn Biotechnology Co Ltd view
CYSB2200097 贝伐珠单抗注射液 bevacizumab Injection Biological Products Supplementary Application 2022-03-25 Suzhou Suncadia Biopharmaceuticals Co Ltd view
CYSB2200055 贝伐珠单抗注射液 bevacizumab Injection Biological Products(原2) Supplementary Application 2022-02-21 Bio-Thera Solutions Ltd view
CYSB2101108 贝伐珠单抗注射液 bevacizumab Injection Biological Products Supplementary Application 2021-07-13 Innovent Biologics (Suzhou) Co Ltd view
CYSB2300112 贝伐珠单抗注射液 bevacizumab Injection Biological Products Supplementary Application 2023-06-12 Shanghai Henlius Biopharmaceutical Co Ltd view
JXSL2200084 贝伐珠单抗注射液 bevacizumab Injection Biological Products(2.2) Import Drug Application 2022-06-13 view
JXSL2200098 贝伐珠单抗注射液 bevacizumab Injection Biological Products(3.3) Import Drug Application 2022-07-02 view
CYSB2101321 贝伐珠单抗注射液 bevacizumab Injection Biological Products(3.3) Supplementary Application 2021-12-31 TOT Biopharm Co Ltd view
CYSB2300174 贝伐珠单抗注射液 bevacizumab Injection Biological Products Supplementary Application 2023-09-26 TOT Biopharm Co Ltd view
CYSB2200057 贝伐珠单抗注射液 bevacizumab Injection Biological Products(原2) Supplementary Application 2022-02-21 Bio-Thera Solutions Ltd view
CYSB2101115 贝伐珠单抗注射液 bevacizumab Injection Biological Products Supplementary Application 2021-07-14 Suzhou Suncadia Biopharmaceuticals Co Ltd view